<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The determination of serum cholesterol, <z:chebi fb="4" ids="17855">triglycerides</z:chebi> and <z:chebi fb="0" ids="50404">lipoprotein cholesterol</z:chebi> (<z:chebi fb="1" ids="39027">VLDL</z:chebi>, <z:chebi fb="15" ids="39026">LDL</z:chebi> and <z:chebi fb="17" ids="39025">HDL</z:chebi>) in 96 patients suffering from cerebral <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> showed that some parameters were significantly different from those recorded in a control population of corresponding age <z:chebi fb="17" ids="39025">HDL</z:chebi> values below 40 mg/dl were found in 50% of cases </plain></SENT>
<SENT sid="1" pm="."><plain>Pathological LDH/<z:chebi fb="17" ids="39025">HDL</z:chebi> and <z:chebi fb="1" ids="39027">VLDL</z:chebi>/<z:chebi fb="17" ids="39025">HDL</z:chebi> ratios were found in 30.9% and 37.7%, respectively, of patients with cerebrovascular disease, whose serum cholesterol level was below 250 mg/dl and <z:chebi fb="0" ids="17855">triglyceride</z:chebi> level was 175 mg/dl </plain></SENT>
<SENT sid="2" pm="."><plain>Only 56% of <z:hpo ids='HP_0000001'>all</z:hpo> patients had <z:hpo ids='HP_0003124'>elevated serum cholesterol</z:hpo> and/<z:chebi fb="0" ids="17855">triglyceride</z:chebi> and <z:chebi fb="0" ids="17855">triglyceride</z:chebi> alone does not detect the risk </plain></SENT>
<SENT sid="3" pm="."><plain>The difference in the <z:chebi fb="1" ids="39027">VLDL</z:chebi>/<z:chebi fb="17" ids="39025">HDL</z:chebi> ratio in patients with cerebrovascular disease and that of the control population is highly significant </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:chebi fb="17" ids="39025">HDL</z:chebi> values and the <z:chebi fb="1" ids="39027">VLDL</z:chebi>/<z:chebi fb="17" ids="39025">HDL</z:chebi> ratio differ significantly, also </plain></SENT>
<SENT sid="5" pm="."><plain>On average, the <z:chebi fb="17" ids="39025">HDL</z:chebi> levels in women are higher than those in men, but the decrease faster with increasing age </plain></SENT>
<SENT sid="6" pm="."><plain>In both sexes a decrease in <z:chebi fb="17" ids="39025">HDL</z:chebi> level occurs between the age of 40 and 80 </plain></SENT>
<SENT sid="7" pm="."><plain>Low <z:chebi fb="17" ids="39025">HDL</z:chebi> levels and unfavourable <z:chebi fb="15" ids="39026">LDL</z:chebi>/<z:chebi fb="17" ids="39025">HDL</z:chebi> and <z:chebi fb="1" ids="39027">VLDL</z:chebi>/<z:chebi fb="17" ids="39025">HDL</z:chebi> quotients are important risk indicators for cerebrovascular disease </plain></SENT>
</text></document>